false 0001864531 0001864531 2024-12-18 2024-12-18 0001864531 us-gaap:CommonStockMember 2024-12-18 2024-12-18 0001864531 us-gaap:WarrantMember 2024-12-18 2024-12-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 18, 2024

 

VSEE HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41015   86-2970927
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

 

980 N Federal Hwy #304
Boca Raton, Florida
  33432
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (561) 672-7068

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Title of each class   Trading
Symbol
  Name of each exchange
on
which registered
Common Stock, $0.0001 par value per share   VSEE   The Nasdaq Stock Market LLC
Warrants, which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share   VSEEW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 7.01. Regulation FD Disclosure.

 

On December 18, 2024, VSee Health, Inc. (the “Company”) issued a press release announcing that it has been awarded a national group purchasing agreement for teleradiology services with Premier, Inc., a leading technology-enabled healthcare improvement company. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference.

 

On December 19, 2024, the Company issued a press release announcing the award of a teleradiology contract with one of the largest post-acute care hospital systems in the United States. A copy of the press release is furnished as Exhibit 99.2 hereto and incorporated herein by reference.

 

The information included in this Item 7.01, Exhibit 99.1, and Exhibit 99.2 of this Current Report on Form 8-K is not deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall this item, Exhibit 99.1 and Exhibit 99.2 be incorporated by reference into the Company’s filings under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such future filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits:

 

Exhibit Description
99.1 Press Release, dated December 18, 2024
99.2 Press Release, dated December 19, 2024
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: December 23, 2024 VSEE HEALTH, INC.
     
  By: /s/ Imoigele Aisiku
  Name: Imoigele Aisiku
  Title: Co-Chief Executive Officer

 

 

 

Exhibit 99.1

 

VSee Health Awarded Teleradiology Services Agreement with Premier, Inc.

 

SAN JOSE, Calif. -- December 18, 2024 --VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow streams and enhance patient care, has been awarded a national group purchasing agreement for teleradiology services with Premier, Inc., a leading technology-enabled healthcare improvement company. Effective September 1, 2024, the new agreement, allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for VSee Health’s teleradiology services.

 

“Our teleradiology services are uniquely designed to address the complex and evolving demands of modern healthcare systems,” said Imo Aisiku, M.D., Co-CEO of VSee Health. “As many health systems continue to face resource constraints and specialist shortages in the wake of the COVID-19 pandemic, this agreement enables us to further expand access to our scalable, cutting-edge telehealth solutions. With teleradiology already gaining significant traction, we are excited to extend this essential service to Premier’s expansive network, ensuring greater access to high-quality care.”

 

Teleradiology services are transforming radiology practice by enabling the remote interpretation of medical imaging, which expedites diagnostics and treatment planning. VSee Health’s teleradiology solutions leverage high-definition video and advanced image-sharing technology to provide radiologists with seamless connectivity to healthcare teams and patients from any location, driving improved patient outcomes and creating operational efficiencies for hospitals and imaging centers.

 

The teleradiology market is a key driver within the expanding global radiology sector, which was valued at $30.0 billion in 2023 and is projected to reach $48.5 billion by 2031, growing at a CAGR of 6.20%. This growth reflects the increasing demand for advanced diagnostic capabilities and remote imaging solutions. The rise of teleradiology is transforming healthcare delivery by ensuring radiology services are accessible to underserved areas, reducing delays in diagnosis, and enabling real-time consultations. By aligning with these trends, VSee Health is strategically positioned to capture market share and deliver value through its innovative, scalable telehealth solutions.

 

Premier is a leading technology-driven healthcare improvement company, providing solutions to two-thirds of all healthcare providers in the U.S. Playing a critical role in the rapidly evolving healthcare industry, Premier unites providers, suppliers, payers and policymakers to make healthcare better with national scale, smarter with actionable intelligence and faster with novel technologies. With integrated data and analytics, collaboratives, supply chain solutions, consulting and other services, Premier enables better care and outcomes at a lower cost.

 

About VSee

 

VSee Health’s AI telehealth platform is the fastest way for enterprises to go from ideation to market go-live. Field-hardened on over 1.5M HIPAA-compliant video encounters every month, its customizable telehealth building blocks each meet stringent government security standards and are ready to scale. VSee Health has traveled for field deployments to over 50 countries such as Iraq, Syria, Marshall Islands and El Salvador. Its clients include NASA Space Station, US Department of Health and Human Services, McKesson, Magellan, DaVita, GE, countless startups, and the entire country of Qatar.

 

VSee Health also provides tailored solutions for critical shortage areas such as critical care and teleradiology. It is committed to empowering high quality healthcare access and reducing physician burnout and workforce shortages through its telehealth technology. Visit vseehealth.com.

 

 

 

 

Forward-Looking Statements

 

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as “believes,” “expects,” “intends,” “plans,” “estimates,” “assumes,” “may,” “should,” “will,” “seeks,” or other similar expressions. Such statements may include, but are not limited to, statements regarding the Company’s ability to regain compliance with Nasdaq’s listing rules within the required timeframe. These statements are based on current expectations on the date of this press release and involve a number of risks and uncertainties that may cause actual results to differ significantly, including those risks set forth in the Company’s most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q and other documents filed with the SEC. Copies of such filings are available on the SEC’s website at www.sec.gov. The Company does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.

 

Contacts

Media:

VSee Health

Anne Chang

1-626-513-1824

media@vsee.com

 

Investor:

Dave Gentry

RedChip Companies

1-407-644-4256

VSEE@redchip.com

 

 

 

 

 

 

Exhibit 99.2

 

VSee Health Secures Teleradiology Contract with Leading Post-Acute Care Hospital System

 

SAN JOSE, Calif-- December 19, 2024 --VSee Health, Inc. (Nasdaq: VSEE), a leader in telehealth solutions, today announced the award of a teleradiology contract with one of the largest post-acute care hospital systems in the United States. This partnership, set to launch in Q1 of 2025, marks the latest addition to VSee’s growing roster of teleradiology customers and reinforces its position as a trusted provider of advanced imaging solutions.

 

The initial rollout will include three hospital locations representing a potential $1.5 million in annual recurring revenue, with the contract structured to automatically renew annually. Through this collaboration, VSee aims to improve diagnostic accuracy, accelerate turnaround times for imaging results, and enhance patient outcomes through seamless, 24/7 radiology interpretations.

 

Highlights of VSee’s Teleradiology Solutions:

 

·Improved Diagnostic Efficiency: Real-time, remote interpretation of X-rays, MRIs, and CT scans, reducing delays in patient diagnosis and treatment initiation.
·Enhanced Flexibility for Radiologists: VSee’s technology enables radiologists to provide expertise from any location, ensuring round-the-clock coverage without disrupting workflow.
·Customizable Cloud Clinic: VSee’s platform allows integration with existing systems, facilitating smooth consultations, second opinions, and real-time collaboration with specialists.

 

“Securing this partnership reflects growing recognition of VSee’s capabilities in delivering scalable telehealth solutions tailored to meet critical healthcare needs,” said Dr. Imo Aisiku, Co-CEO and Chairman of VSee Health. “By offering streamlined radiology workflows and unparalleled access to top-tier radiology expertise, we are empowering post-acute care providers to deliver faster, higher-quality care for their patients.”

 

VSee’s teleradiology services leverage cutting-edge telemedicine tools to connect radiologists with healthcare providers across hospitals, nursing facilities, and mobile clinics. Through cloud-based imaging platforms, radiologists can interpret scans, collaborate with physicians, and consult with patients in real-time, eliminating geographic limitations and improving operational efficiency.

 

The U.S. teleradiology market is poised for rapid growth, driven by rising demand for timely diagnostics and the increasing adoption of telemedicine in post-acute care settings. VSee’s growing presence in this market underscores the company’s leadership in delivering critical solutions that modernize healthcare delivery.

 

About VSee Health

 

VSee Health is a leading provider of telehealth solutions, specializing in real-time virtual care, clinical review, and billing services. Its technology powers healthcare networks and organizations worldwide, enabling seamless patient-provider interactions and ensuring efficient care delivery. Field-hardened on over 1.5M HIPAA-compliant video encounters every month, VSee Health’s highly scalable, customizable telehealth building blocks each meet stringent security standards. VSee Health has deployed services in over 50 countries, including Iraq, Syria, Marshall Islands and El Salvador. Its clients include NASA, US Department of Health and Human Services, McKesson, Magellan, DaVita, GE, countless startups, and the entire country of Qatar. VSee Health also provides tailored solutions for critical shortage areas such as critical care and teleradiology. VSee Health is committed to empowering high quality healthcare access and reducing physician burnout and workforce shortages through its telehealth technology. For more information, please visit www.vseehealth.com.

 

 

 

 

Forward-Looking Statements

 

Matters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health’s ability to improve healthcare access and provider efficiencies, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the “Cautionary Note Regarding Forward-Looking Statements,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of VSee Health’s periodic and current filings with the SEC, which are also made available on VSee Health’s website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.

 

Contacts

Dave Gentry, CEO

RedChip Companies, Inc.

1-407-644-4256

VSEE@redchip.com

 

 

 

v3.24.4
Cover
Dec. 18, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 18, 2024
Entity File Number 001-41015
Entity Registrant Name VSEE HEALTH, INC.
Entity Central Index Key 0001864531
Entity Tax Identification Number 86-2970927
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 980 N Federal Hwy #304
Entity Address, City or Town Boca Raton
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33432
City Area Code 561
Local Phone Number 672-7068
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Common Stock [Member]  
Title of 12(b) Security Common Stock, $0.0001 par value per share
Trading Symbol VSEE
Security Exchange Name NASDAQ
Warrant [Member]  
Title of 12(b) Security Warrants, which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share
Trading Symbol VSEEW
Security Exchange Name NASDAQ

VSee Health (NASDAQ:VSEEW)
Historical Stock Chart
Von Nov 2024 bis Dez 2024 Click Here for more VSee Health Charts.
VSee Health (NASDAQ:VSEEW)
Historical Stock Chart
Von Dez 2023 bis Dez 2024 Click Here for more VSee Health Charts.